Equities

Ondine Biomedical Inc

OBI:LSE

Ondine Biomedical Inc

Health CarePharmaceuticals and Biotechnology
  • Price (GBX)8.38
  • Today's Change0.375 / 4.69%
  • Shares traded170.38k
  • 1 Year change-33.00%
  • Beta--
Data delayed at least 20 minutes, as of Oct 31 2024 16:25 BST.
More ▼

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of CAD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
REVENUE AND GROSS PROFIT
Total revenue1.200.642.57
OPERATING EXPENSES
Cost of revenue total0.500.351.32
Selling, general and admin. expenses, total9.801213
Depreciation/amortization0.570.460.46
Unusual expense(income)01.3332
Other operating expenses, total------
Total operating expense162152
Operating income(15)(20)(49)
Other, net0.430.000.50
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes(14)(19)(50)
Provision for income taxes------
Net income after taxes(14)(19)(50)
Minority interest------
Net income before extra. Items(14)(19)(50)
Total extraordinary items------
Net income(14)(19)(50)
Inc.avail. to common excl. extra. Items(14)(19)(50)
Inc.avail. to common incl. extra. Items(14)(19)(50)
EPS RECONCILIATION
Basic/primary weighted average shares19719580
Basic/primary eps excl. extra items(0.07)(0.1)(0.63)
Basic/primary eps incl. extra items(0.07)(0.1)(0.63)
Dilution adjustment------
Diluted weighted average shares19719580
Diluted eps excl. extra items(0.07)(0.1)(0.63)
Diluted eps incl. extra items(0.07)(0.1)(0.63)
COMMON STOCK DIVIDENDS
DPS - common stock primary issue------
Gross dividend - common stock00--
PRO FORMA INCOME
Pro forma net income------
Interest expense, supplemental0.050.030.11
SUPPLEMENTAL INCOME
Depreciation, supplemental0.590.490.34
Total special items0.101.4132
NORMALISED INCOME
Normalized income before taxes(14)(18)(18)
Effect of special items on income taxes000
Income tax excluding impact of special items000
Normalized income after tax(14)(18)(18)
Normalized income avail. to common(14)(18)(18)
Basic normalized EPS(0.07)(0.09)(0.23)
Diluted normalized EPS(0.07)(0.09)(0.23)
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.